CXCR4 antagonists for treatment of breast cancer
Oncotarget
.
2018 Sep 11;9(71):33442-33443.
doi: 10.18632/oncotarget.26090.
Authors
Javier Cortés
1
,
Esther Holgado
1
,
Jose Perez-Garcia
1
Affiliation
1
Javier Cortés: Ramon y Cajal University Hospital, Madrid, Spain; Vall d´Hebron Institute of Oncology, Barcelona, Spain; IOB Institute of Oncology, QuironGroup, Madrid & Barcelona, Spain.
PMID:
30323888
PMCID:
PMC6173365
DOI:
10.18632/oncotarget.26090
No abstract available
Keywords:
CXCR4 antagonists; balixafortide; breast cancer; eribulin; oncology.
Publication types
Editorial